NCT05388526 is a clinical trial of No intervention in Parkinson Disease, sponsored by University of Oviedo.

Who is sponsoring NCT05388526?

NCT05388526 is sponsored by University of Oviedo.

What drugs are being tested in NCT05388526?

Interventions in NCT05388526: No intervention.

What condition does NCT05388526 study?

NCT05388526 studies Parkinson Disease.

Is NCT05388526 still recruiting?

NCT05388526 is currently completed. Last updated 21 December 2023.

Last reviewed 2023-12-21 · How we verify

NCT05388526

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Frailty and Cognitive Function in Parkinson's Disease.

Completed Last updated 21 December 2023

What this trial tests

trial testing No intervention in Parkinson Disease in 100 participants. Completed in 30 June 2023.

Timeline

25 May 2022

Primary endpoint
31 May 2023

30 June 2023

Quick facts

Lead sponsor	University of Oviedo
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	25 May 2022
Primary completion	31 May 2023
Estimated completion	30 June 2023
Sites	1 location across Spain

Drugs / interventions tested

No intervention

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

University of Oviedo

Who can join

Eligibility, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: Parkinson's disease (PD) is the association of tremor, rigidity, akinesia-bradykinesia and loss of postural reflexes. Non-motor symptoms such as cognitive impairment may also develop. Cognitive impairment can be highly variable in its progression, symptoms and severity and can begin from the onset of the disease to the most advanced stages. Frailty is a syndrome characterized by a decrease in physiological reserve that results in an individual's increased vulnerability, which can lead to a variety of adverse factors when exposed to stressors. PD and frailty are highly prevalent in older people and are associated with increased morbidity and mortality. The presence of frailty in patients with PD is poorly studied, as is the association between cognitive impairment and frailty in this patient profile. Objective: Evaluate the relationship between frailty and cognitive impairment in patients with PD or secondary parkinsonism. Study design: observational, descriptive, correlative and cross-sectional. Study population: The subjects that will be part of this study will be men and women with a diagnosis of PD or secondary parkinsonism belonging to the Health Area V of the Health Service of the Principality of Asturias, Spain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Associations between frailty and cognitive impairment in Parkinson´s disease: a cross-sectional study.
Sousa-Fraguas MC, Rodríguez-Fuentes G, Lastra-Barreira D, Conejo NM. · · 2025 · cited 4× · PMID 39751989 · DOI 10.1007/s40520-024-02922-4

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other University of Oviedo trials

Trials by the same sponsor.

NCT07419386 — Clinical and Psychosocial Factors Associated With Physical Activity Level in Adults With Marfan Syndrome · not yet recruiting
NCT07408765 — Physical Activity, Fatigue, Social Support, and Psychological Well-Being in Women With Primary Hypothyroidism · recruiting
NCT07406802 — Association Between Racket Stiffness and Lateral Epicondylalgia in Tennis Players · recruiting
NCT07408700 — Influence of Training Surface and Mechanical Load on the Prevalence of Patellofemoral Pain in Recreational Runners · recruiting
NCT07408739 — Association Between Weekly Strength Training Load and Perceived Physical Performance in Non-Professional Soccer Players · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05388526 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oviedo
Last refreshed: 21 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05388526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing